William Slattery | executive |
Pravin Dugel | executive |
Tazeen Ahmad | analyst |
Biren Amin | analyst |
Tara Bancroft | analyst |
Colleen Hanley | analyst |
Dingding Shi | analyst |
Sean McCutcheon | analyst |
Yi Chen | analyst |
Good morning, and welcome to the Ocular Therapeutix Second Quarter 2024 Earnings Conference Call. [Operator Instructions]
As a reminder, this conference call is being recorded and will be available for replay on the Investor Relations section of the Ocular Therapeutix website.
I would now like to turn the call over to Ocular's Vice President of Investor Relations, Bill Slattery. Please go ahead, Mr.